Research and Markets: Glioblastoma Multiforme (GBM) – Pipeline Review, H1 2012

Posted: March 19, 2012 at 9:33 pm

DUBLIN--(BUSINESS WIRE)--

Research and Markets(http://www.researchandmarkets.com/research/f8a4c2/glioblastoma_multi) has announced the addition of Global Markets Direct's new report "Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2012" to their offering.

Global Markets Direct's, 'Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2012', provides an overview of the Glioblastoma Multiforme (GBM) therapeutic pipeline. This report provides information on the therapeutic development for Glioblastoma Multiforme (GBM), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Glioblastoma Multiforme (GBM). 'Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Key Topics Covered:

For more information visit http://www.researchandmarkets.com/research/f8a4c2/glioblastoma_multi

Continue reading here:
Research and Markets: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2012

Related Posts

Comments are closed.

Archives